Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
Recruiting · NCT06046131 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Universitaire de la Guadeloupe
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographic origins of the individuals. The general objective of the project is to identify the clinical, genetic and environmental determinants (risk factors) of the evolution, progression and complications of the disease according to the treatment options. Identifying modifiable and non-modifiable prognostic determinants of disease progression is a major challenge. This knowledge will help guide treatment choices but also, especially in high-risk populations (high incidence of disease) to better tailor prevention policies and possibly screening .
Who can take part
Inclusion criteria
- Inclusion criteria:
- Adult patients with incident case of prostate cancer Patient consulting the University Hospital of Guadeloupe or the University Hospital of Rennes Patient who resides in the departments of Guadeloupe or Martinique or the community of Saint-Martin or in Britany Patient affiliated or beneficiary of the social security signed consent
Exclusion criteria
- Physical or mental health judjed by the investigator as precluding participation in the research Protected adults (guardianship, curatorship, safeguard of justice).
Where it is running
2 locations listed.
- CHU of Guadeloupe - Pointe-à-Pitre, Guadeloupe, Guadeloupe
- CHU of Rennes - Rennes, Ille-et-Vilaine, France